Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaodi Wen

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Stem Cells International|July 26, 2021
Gastric Cancer Mesenchymal Stem Cells Inhibit NK Cell Function through mTOR Signalling to Promote Tumour GrowthShuwei Guo, Chao Huang, Fengfeng Han, et al.
Frontiers in Immunology|January 5, 2026
SAA restricts T cell mediated anti-tumor immunity by limiting antigen presentation in lung cancerMei Huang, Run Shi, Cong Xu, et al.
Frontiers in Immunology|January 31, 2022
Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular CarcinomaShaodi Wen, Yuzhong Chen, Chupeng Hu, et al.
Cancer Medicine|September 14, 2024
The efficacy of neoadjuvant immunotherapy and lymphocyte subset predictors in locally advanced esophageal squamous cell carcinoma: A retrospective studyRuotong Wang, Shaodi Wen, Xiaoyue Du, et al.
BMC Cancer|January 25, 2023
Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: a retrospective studyXiaoyue Du, Shaodi Wen, Run Shi, et al.
Frontiers in Immunology|May 16, 2022
Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem CellsQianqian Wang, Chao Huang, Ying Ding, et al.
Translational Lung Cancer Research|June 13, 2022
Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective studyShaodi Wen, Xiaoyue Du, Yuzhong Chen, et al.
Chinese Medical Journal|July 23, 2024
Reducing language barriers, promoting information absorption, and communication using fanyiDifei Wang, Guannan Chen, Lin Li, et al.
Journal for Immunotherapy of Cancer|October 10, 2025
ALCAM-CD6 axis suppression: a key determinant of immune-mediated metastasis recurrence in stage III non-small cell lung cancerShaodi Wen, Xiaoyue Du, Miaolin Zhu, et al.
Annals of Translational Medicine|July 11, 2022
Efficacy and safety of second-line therapy with apatinib combined with chemotherapy as second-line therapy in advanced gastric cancer: a single-arm, open-label, prospective, multicenter studyYan Zhang, Junying Xu, Qiong Wang, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Stem Cells International|July 26, 2021
Gastric Cancer Mesenchymal Stem Cells Inhibit NK Cell Function through mTOR Signalling to Promote Tumour GrowthShuwei Guo, Chao Huang, Fengfeng Han, et al.
Frontiers in Immunology|January 5, 2026
SAA restricts T cell mediated anti-tumor immunity by limiting antigen presentation in lung cancerMei Huang, Run Shi, Cong Xu, et al.
Frontiers in Immunology|January 31, 2022
Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular CarcinomaShaodi Wen, Yuzhong Chen, Chupeng Hu, et al.
Cancer Medicine|September 14, 2024
The efficacy of neoadjuvant immunotherapy and lymphocyte subset predictors in locally advanced esophageal squamous cell carcinoma: A retrospective studyRuotong Wang, Shaodi Wen, Xiaoyue Du, et al.
BMC Cancer|January 25, 2023
Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: a retrospective studyXiaoyue Du, Shaodi Wen, Run Shi, et al.
Frontiers in Immunology|May 16, 2022
Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem CellsQianqian Wang, Chao Huang, Ying Ding, et al.
Translational Lung Cancer Research|June 13, 2022
Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective studyShaodi Wen, Xiaoyue Du, Yuzhong Chen, et al.
Chinese Medical Journal|July 23, 2024
Reducing language barriers, promoting information absorption, and communication using fanyiDifei Wang, Guannan Chen, Lin Li, et al.
Journal for Immunotherapy of Cancer|October 10, 2025
ALCAM-CD6 axis suppression: a key determinant of immune-mediated metastasis recurrence in stage III non-small cell lung cancerShaodi Wen, Xiaoyue Du, Miaolin Zhu, et al.
Annals of Translational Medicine|July 11, 2022
Efficacy and safety of second-line therapy with apatinib combined with chemotherapy as second-line therapy in advanced gastric cancer: a single-arm, open-label, prospective, multicenter studyYan Zhang, Junying Xu, Qiong Wang, et al.
Pageof 3